Irreproducible life sciences research in U.S. costs $28 billion

Problems with preclinical studies often stem from flaws in experimental design and materials

flaws in research

BIG SPENDERS  Preclinical research is all too often irreproducible. Its flaws, which tend to stem from four broad categories, cost big bucks.

L.P. Freedman, I.M. Cockburn and T.S. Simcoe/PLOS Biology 2015, adapted by M. Telfer

This article is only available to Science News subscribers.

Subscribers, enter your e-mail address to access our archives.

Not a subscriber?

Science News is a nonprofit.

Support us by subscribing now.

More Stories from Science News on Science & Society

From the Nature Index

Paid Content